BIOVENTUS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$13.33
-10.39%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-0.9%
3 months
-1.1%
6 months
+31.8%
1 year
+96.8%
Year to date
+79.1%
52-week range
$6.53 – $15.26
Fundamental snapshot
Latest reported period: Jun 27, 2026
Market cap
$1.12B
P/E
20.6
P/B
4.9
P/S
1.9
Revenue
$581.85M
Net income
$54.46M
Diluted EPS
0.77
Gross margin
68.70%
Net margin
9.40%
Return on equity
28.40%
Total debt
$248.45M
Cash
$29.46M
Free cash flow
$94.29M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 27, 2026 | $153.21M | $33.44M | 69.00% | 21.80% | $18.91M |
| Mar 28, 2026 | $132.09M | $3.11M | 68.70% | 2.40% | $8.36M |
| Dec 31, 2025 | $157.9M | $14.76M | 68.90% | 9.30% | $37.39M |
| Sep 27, 2025 | $138.65M | $3.16M | 68.00% | 2.30% | $29.63M |
| Jun 28, 2025 | $147.66M | $7.46M | 69.10% | 5.10% | $25.26M |
| Mar 29, 2025 | $123.88M | -$2.64M | 67.00% | -2.10% | -$20.16M |
| Dec 31, 2024 | $153.64M | -$156K | 66.80% | -0.10% | $18.75M |
| Sep 28, 2024 | $138.96M | -$4.82M | 67.30% | -3.50% | $10.25M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent BVS news
All market newsNo ticker-linked stories are in the current archive.